CMG Pharmaceutical

CMG제약 · 058820

Health Care Pharmaceuticals · KOSDAQ

Small-cap

Market cap US$125.9M (₩173.7B)

Overview

CMG Pharmaceutical makes medicines and health-supplement products, with a core focus on a thin, fast-dissolving oral film, a strip placed on the tongue that delivers a drug without water, using its proprietary STARFILM Technology.

Its products reach patients and consumers through pharmaceutical and health-care channels. Listed on KOSDAQ, Korea's tech and small-cap board, the company is expanding its product portfolio beyond its current medicines into oncology, anti-aging, eye care, health supplements, and mother-and-baby categories, while also pursuing new and improved-formulation drug development.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025
Revenue · FY2025
US$76.3M
▲ +6.2% YoY
Operating profit · FY2025
−US$2.7M
Turned to loss
Net income · FY2025
−US$7.3M
Turned to loss

Revenue

  • FY2023US$68M
  • FY2024US$71.8M
  • FY2025US$76.3M

Operating profit

  • FY2023US$2.2M
  • FY2024US$739.4K
  • FY2025−US$2.7M

Net income

  • FY2023US$4.7M
  • FY2024US$2M
  • FY2025−US$7.3M

Key ratios (FY2025)

ROE
-5.0%
Debt/Eq
51.8%
Op. margin
-3.5%
Net margin
-9.6%
Rev. YoY
▲ +6.2%

Why it matters

CMG Pharmaceutical is described in its filing as a core affiliate of the Cha Bio Group, a Korean life-sciences conglomerate.

Price charts coming soon

Interactive price history isn't here yet. Would you use it?

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-06-12 (KST). · FX: 1 USD ≈ ₩1,380 (2026-06-01).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.